A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
Not Applicable
Completed
- Conditions
- Meningitis, CryptococcalHIV Infections
- Registration Number
- NCT00002294
- Lead Sponsor
- Pfizer
- Brief Summary
To compare the safety and effectiveness of fluconazole with that of placebo as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Dr Robert Larsen
🇺🇸Los Angeles, California, United States
UCI Med Ctr
🇺🇸Orange, California, United States
UCSD
🇺🇸San Diego, California, United States
Dr Paul Rothman
🇺🇸Sherman Oaks, California, United States
Stanford Univ School of Medicine
🇺🇸Stanford, California, United States
Dr Robert Larsen🇺🇸Los Angeles, California, United States